Cases of the respiratory illness are rising in January 2026 across the state, including in the Sacramento area.
BabyCenter on MSN
RSV symptoms in babies and children: When it's just a cold, and when to call the doctor
RSV often looks like a cold – but sometimes it's more serious. Here's when to call the doctor and how to help your child feel ...
A new shot is helping protect more babies from RSV. A Dayton doctor said it is already dramatically reducing hospitalizations ...
Local doctors report a sharp rise in cases and increased hospital precautions, while urging residents to stay vigilant with ...
NEW YORK, NY, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- Public health expert Dr. Syra Madad and Critical ...
Giving the long-acting monoclonal antibody nirsevimab to most infants sharply reduced hospitalizations and clinic visits ...
Peak season ranges from late December to mid-February every year, the CDC website says. Last year in North Carolina, RSV ...
MedPage Today on MSN
Will Progress on Protecting Young Kids From RSV Be Reversed?
In 2023, the FDA and CDC's Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the monoclonal ...
The CDC and the American Academy of Pediatrics recommend the RSV monoclonal antibody treatment Beyfortus for babies under 8 ...
NEW YORK CITY -- In September, an 8-month-old baby came into Dr. Juanita Mora's office in Chicago with an infection the doctor hadn't expected to see for another two months: RSV. Like her peers across ...
Straight Arrow News (English) on MSN
Studies find RSV protection for infants cuts hospitalizations
As the number of RSV infections rises, two recent studies found that protecting babies against the disease prevented ...
Nirsevimab, a long-acting monoclonal antibody that confers passive immunity for infants up to 6 months old, was approved in 2023 to prevent RSV-related LRTIs in infants in their first year of life, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results